Investments

Established in 1997, M-Group has to date made many investments in Australian and US companies.

Some examples of investments by M-Group and its principals include :-

McMillan Shakespeare Ltd - Australia 's leading supplier of salary packaging services - An M-Group affiliate coordinated the Leveraged Management Buy-Out of the company from Zurich Australia Ltd, provided capital and managed the company’s IPO on the ASX which was the most successful industrial listing in 2004. (www.msa-online.com.au)

SciVentures Pty Ltd – M-Group is the majority and cornerstone private investor in this fund which was awarded one of four AusIndustry Pre-Seed Fund licenses by the Federal Government. M-Group's co-investors include CSIRO and nine Australian Universities (www.sciventures.com.au)

Cellestis Ltd - Developer of medical diagnostic technology with initial products to diagnose latent TB. An M-Group affiliate was a key partner in the establishment of Cellestis in 2000, has provided capital and managed the companies IPO on the ASX. Since inception Cellestis has achieved widespread international regulatory approvals for its products and has established a dynamic and successful team of sales professionals in 7 countries.  Cellestis’ listing on the ASX was the most successful by share market return in 2000. (www.cellestis.com)

Pharmaxis Ltd - developer of treatments and diagnostic products for auto-immune diseases including cystic fibrosis, MS and asthma – M-Group invested $2.5 million in this company which is now listed on the ASX (www.pharmaxis.com.au)

Cohda Wireless Pty Ltd – Cohda Wireless have patented technology which allows standards-based WiFi networks to operate reliably when a user is moving at high speed. The company is heavily engaged in trials of this technology for governments and major auto-industry players in the USA and Europe and is helping to set the standards for emerging Intelligent Transportation Systems (ITS). M-Group, together with Sci-Ventures has led two rounds of investment (www.cohdawireless.com)

Inlink Pty Ltd – M-Group has provided two rounds of investment as well as strategic support to Inlink. The company has patented technology applied to the placement of video advertising in the lifts of high-rise office buildings. Currently the company has provided equipment, and places advertisements in more than 1000 lifts in prestige buildings throughout Australia (www.inlink.com.au)

Patrys Ltd - is the developer of world-leading anti-body therapeutic technology for cancer treatment.  It has a deep pipeline of product candidates which are being advanced in the company's facilities in Europe and the United States . M-Group has provided mezzanine capital to the company. (www.patrys.com)

Aqua Diagnostic Pty Ltd - Aqua Diagnostic’s mission is to become an international supplier of innovative water analysis technologies. Aqua Diagnostic is commercializing a range of products based on its PeCOD™ technology with its initial focus on the rapidly growing global water management market. M-Group has provided private equity investment to the company. (www.aquadiagnostic.com)

Haliplex Pty Ltd - designer of optical networking computer hardware – M-Group invested and continues to provide commercial assistance in Australia and the USA.. Haliplex has recently signed a major OEM deal with Nokia. (www.haliplex.com.au)

Evogenix Ltd – has unique technology for the humanization and optimization of human antibodies. M-Group provided mezzanine financing to Evogenix prior to its listing on the ASX in August 2005. (www.evogenix.com.au)

DDNi inc – The battle for screen real estate on a new PC is just starting. DDNi provides PC manufacturers with an eCommerce system that appears on the PC screen at first boot. It allows the PC user to select/acquire the software they wish to use without being swayed by a standard screen from Microsoft. DDNi OEM’s their Oasis software to Lenovo and is ramping revenues rapidly.